BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010;298:50-63. [PMID: 20619534 DOI: 10.1016/j.canlet.2010.06.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 192] [Article Influence: 16.2] [Reference Citation Analysis]
Number Citing Articles
1 Tomasetti M, Nocchi L, Staffolani S, Manzella N, Amati M, Goodwin J, Kluckova K, Nguyen M, Strafella E, Bajzikova M, Peterka M, Lettlova S, Truksa J, Lee W, Dong LF, Santarelli L, Neuzil J. MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function. Antioxid Redox Signal 2014;21:2109-25. [PMID: 24444362 DOI: 10.1089/ars.2013.5215] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
2 Zhu X, Li H, Long L, Hui L, Chen H, Wang X, Shen H, Xu W. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim Biophys Sin (Shanghai). 2012;44:519-526. [PMID: 22510476 DOI: 10.1093/abbs/gms026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
3 Henry JC, Azevedo-pouly ACP, Schmittgen TD. microRNA Replacement Therapy for Cancer. Pharm Res 2011;28:3030-42. [DOI: 10.1007/s11095-011-0548-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 8.2] [Reference Citation Analysis]
4 Li P, Chen X, Su L, Li C, Zhi Q, Yu B, Sheng H, Wang J, Feng R, Cai Q, Li J, Yu Y, Yan M, Liu B, Zhu Z. Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One 2013;8:e66782. [PMID: 23826132 DOI: 10.1371/journal.pone.0066782] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
5 Liu GH, Liu YH, Yang Z, Zhu AL, Zhao CL. MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells. Oncol Lett 2016;11:1926-32. [PMID: 26998102 DOI: 10.3892/ol.2016.4143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci 2012;103:620-5. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
7 Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Kebebew E. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 2011;18:3443-52. [PMID: 21553140 DOI: 10.1245/s10434-011-1766-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
8 Santulli G. microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Adv Exp Med Biol 2015;887:53-77. [PMID: 26662986 DOI: 10.1007/978-3-319-22380-3_4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
9 Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Int J Cancer. 2016;138:2732-2744. [PMID: 26756996 DOI: 10.1002/ijc.29999] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
10 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
11 Xiong Y, Kotian S, Zeiger MA, Zhang L, Kebebew E. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer. PLoS One 2015;10:e0130496. [PMID: 26244545 DOI: 10.1371/journal.pone.0130496] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
12 Luo D, Fan H, Ma X, Yang C, He Y, Ge Y, Jiang M, Xu Z, Yang L. miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer. Front Oncol 2021;11:664242. [PMID: 33987098 DOI: 10.3389/fonc.2021.664242] [Reference Citation Analysis]
13 Chu F, Hu Y, Zhou Y, Guo M, Lu J, Zheng W, Xu H, Zhao J, Xu L. MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway. Clin Exp Immunol 2018;191:166-79. [PMID: 28987000 DOI: 10.1111/cei.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
14 Soon P, Kiaris H. MicroRNAs in the tumour microenvironment: big role for small players. Endocr Relat Cancer 2013;20:R257-67. [PMID: 23878074 DOI: 10.1530/ERC-13-0119] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
15 Darnet S, Moreira FC, Hamoy IG, Burbano R, Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, Assumpção M, Assumpção P, Ribeiro-dos-santos Â. High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential Biomarkers. Bioinform Biol Insights 2015;9s1:BBI.S23773. [DOI: 10.4137/bbi.s23773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
16 Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, Yan M, Zhu Z, Liu B. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. PLoS One 2016;11:e0158961. [PMID: 27518872 DOI: 10.1371/journal.pone.0158961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
17 Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011;91:579-587. [PMID: 21116241 DOI: 10.1038/labinvest.2010.194] [Cited by in Crossref: 259] [Cited by in F6Publishing: 258] [Article Influence: 21.6] [Reference Citation Analysis]
18 Wang J, Chen X, Li P, Su L, Yu B, Cai Q, Li J, Yu Y, Liu B, Zhu Z. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126. Chemico-Biological Interactions 2013;206:230-8. [DOI: 10.1016/j.cbi.2013.09.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
19 Luo P, Fei J, Zhou J, Zhang W. microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells. Oncol Lett 2015;9:2225-9. [PMID: 26137045 DOI: 10.3892/ol.2015.3012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
20 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci. 2012;103:620-625. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Rahman MA, Salajegheh A, Smith RA, Lam AK. MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway. Exp Cell Res 2015;339:342-50. [PMID: 26384552 DOI: 10.1016/j.yexcr.2015.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
22 Kumar S, Fajardo JE, Birge RB, Sriram G. Crk at the quarter century mark: perspectives in signaling and cancer. J Cell Biochem. 2014;115:819-825. [PMID: 24356912 DOI: 10.1002/jcb.24749] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
23 Sabry D, El-Deek SEM, Maher M, El-Baz MAH, El-Bader HM, Amer E, Hassan EA, Fathy W, El-Deek HEM. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Mol Cell Biochem 2019;454:177-89. [PMID: 30357530 DOI: 10.1007/s11010-018-3462-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
24 Akbari Moqadam F, Boer JM, Lange-Turenhout EA, Pieters R, den Boer ML. Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells. Leukemia 2014;28:1008-14. [PMID: 24153013 DOI: 10.1038/leu.2013.308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
25 Shi M, Liu D, Duan H, Shen B, Guo N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 2010;29:785-99. [DOI: 10.1007/s10555-010-9265-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
26 Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII. Nat Chem Biol 2012;8:590-6. [PMID: 22581121 DOI: 10.1038/nchembio.954] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
27 Zhao X, Zhu D, Lu C, Yan D, Li L, Chen Z. MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1. Oncol Lett 2016;11:1207-12. [PMID: 26893720 DOI: 10.3892/ol.2015.4001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
28 Petty RD, McCarthy NE, Le Dieu R, Kerr JR. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME). PLoS One 2016;11:e0150904. [PMID: 26967895 DOI: 10.1371/journal.pone.0150904] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
29 Li Q, Li J, Dai W, Li YX, Li YY. Differential regulation analysis reveals dysfunctional regulatory mechanism involving transcription factors and microRNAs in gastric carcinogenesis. Artif Intell Med 2017;77:12-22. [PMID: 28545608 DOI: 10.1016/j.artmed.2017.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
30 Nothnick WB. MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis. Semin Reprod Med 2017;35:173-80. [PMID: 28212593 DOI: 10.1055/s-0037-1599089] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
31 Xu YJ, Fan Y. MiR-215/192 participates in gastric cancer progression. Clin Transl Oncol. 2015;17:34-40. [PMID: 24981590 DOI: 10.1007/s12094-014-1194-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
32 Moradi Sarabi M, Zahedi SA, Pajouhi N, Khosravi P, Bagheri S, Ahmadvand H, Shahryarhesami S. The effects of dietary polyunsaturated fatty acids on miR-126 promoter DNA methylation status and VEGF protein expression in the colorectal cancer cells. Genes Nutr. 2018;13:32. [PMID: 30598703 DOI: 10.1186/s12263-018-0623-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
33 Hossain S, Dubielecka PM, Sikorski AF, Birge RB, Kotula L. Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton. Genes Cancer 2012;3:402-13. [PMID: 23226578 DOI: 10.1177/1947601912460051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
34 Hu M, Xiong S, Chen Q, Zhu S, Zhou X. Novel role of microRNA-126 in digestive system cancers: From bench to bedside. Oncol Lett 2019;17:31-41. [PMID: 30655735 DOI: 10.3892/ol.2018.9639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
35 Feng R, Li J, Sah BK, Yuan F, Jin X, Yan M, Liu B, Li C, Zhu Z. Overexpression of CrkL as a novel biomarker for poor prognosis in gastric cancer. Cancer Biomark 2019;26:131-8. [PMID: 31356198 DOI: 10.3233/CBM-192435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci. 2015;22:9. [PMID: 25614041 DOI: 10.1186/s12929-015-0113-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 11.9] [Reference Citation Analysis]
37 Tamura M, Sasaki Y, Kobashi K, Takeda K, Nakagaki T, Idogawa M, Tokino T. CRKL oncogene is downregulated by p53 through miR-200s. Cancer Sci 2015;106:1033-40. [PMID: 26079153 DOI: 10.1111/cas.12713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
38 Rufino-palomares EE, Reyes-zurita FJ, Lupiáñez JA, Medina PP. MicroRNAs as Oncogenes and Tumor Suppressors. In: Lawrie CH, editor. MicroRNAs in Medicine. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 223-43. [DOI: 10.1002/9781118300312.ch14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Liu X, Zhang X, Zhang Z, Chang J, Wang Z, Wu Z, Wang C, Sun Z, Ge X, Geng R, Tang W, Dai C, Lin Y, Lin F, Sun M, Jia W, Xue W, Ji J, Hu Y, Qin G, Li J. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer. Int J Cancer 2017;141:2093-102. [PMID: 28722210 DOI: 10.1002/ijc.30895] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
40 Gennart I, Petit A, Wiggers L, Pejaković S, Dauchot N, Laurent S, Coupeau D, Muylkens B. Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease. Microorganisms 2021;9:1339. [PMID: 34205549 DOI: 10.3390/microorganisms9061339] [Reference Citation Analysis]
41 Liu Y, Cai Q, Bao PP, Su Y, Cai H, Wu J, Ye F, Guo X, Zheng W, Zheng Y, Shu XO. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. Breast Cancer Res Treat 2015;152:183-91. [PMID: 26062749 DOI: 10.1007/s10549-015-3460-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
42 Wang Z, Ma X, Cai Q, Wang X, Yu B, Cai Q, liu B, Zhu Z, Li C. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 2014;588:4504-4512. [PMID: 25448600 DOI: 10.1016/j.febslet.2014.09.047] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
43 Yan Z, Zhou Z, Li C, Yang X, Yang L, Dai S, Zhao J, Ni H, Shi L, Yao Y. Polymorphisms in miRNA genes play roles in the initiation and development of cervical cancer. J Cancer 2019;10:4747-53. [PMID: 31598146 DOI: 10.7150/jca.33486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Suzuki HI, Katsura A, Matsuyama H, Miyazono K. MicroRNA regulons in tumor microenvironment. Oncogene 2015;34:3085-94. [PMID: 25132266 DOI: 10.1038/onc.2014.254] [Cited by in Crossref: 111] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
45 Sriram G, Birge RB. Emerging roles for crk in human cancer. Genes Cancer 2010;1:1132-9. [PMID: 21779437 DOI: 10.1177/1947601910397188] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
46 Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res 2014;42:7528-38. [PMID: 24875473 DOI: 10.1093/nar/gku461] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 16.8] [Reference Citation Analysis]
47 Feng R, Beeharry MK, Lu S, Sah BK, Yuan F, Yan M, Liu B, Li C, Zhu Z. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer. Cancer Biomark 2018;22:119-26. [PMID: 29562500 DOI: 10.3233/CBM-171099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Ebrahimi F, Gopalan V, Smith RA, Lam AK. miR-126 in human cancers: Clinical roles and current perspectives. Experimental and Molecular Pathology 2014;96:98-107. [DOI: 10.1016/j.yexmp.2013.12.004] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 13.5] [Reference Citation Analysis]
49 Lu YY, Sweredoski MJ, Huss D, Lansford R, Hess S, Tirrell DA. Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126. ACS Chem Biol 2014;9:334-8. [PMID: 24274104 DOI: 10.1021/cb400704n] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
50 Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazović E, Radojević Z, Košnik M. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLoS One 2012;7:e45577. [PMID: 23029111 DOI: 10.1371/journal.pone.0045577] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
51 Ishihara K, Sasaki D, Tsuruda K, Inokuchi N, Nagai K, Hasegawa H, Yanagihara K, Kamihira S. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol 2012;36:560-5. [PMID: 22884882 DOI: 10.1016/j.canep.2012.07.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
52 Patella F, Rainaldi G. MicroRNAs mediate metabolic stresses and angiogenesis. Cell Mol Life Sci 2012;69:1049-65. [DOI: 10.1007/s00018-011-0775-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
53 Tomasetti M, Neuzil J, Dong L. MicroRNAs as regulators of mitochondrial function: role in cancer suppression. Biochim Biophys Acta 2014;1840:1441-53. [PMID: 24016605 DOI: 10.1016/j.bbagen.2013.09.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
54 Sun LL, Li WD, Lei FR, Li XQ. The regulatory role of microRNAs in angiogenesis-related diseases. J Cell Mol Med 2018;22:4568-87. [PMID: 29956461 DOI: 10.1111/jcmm.13700] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
55 Ito Y, Hart JR, Ueno L, Vogt PK. Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K). Proc Natl Acad Sci U S A 2014;111:16826-9. [PMID: 25385636 DOI: 10.1073/pnas.1420281111] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
56 Xu X, Wang W, Su N, Zhu X, Yao J, Gao W, Hu Z, Sun Y. miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer. FEBS Lett. 2015;589:407-413. [PMID: 25554419 DOI: 10.1016/j.febslet.2014.12.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
57 Zhou W, Nie J, Zhang D. [Differential expression of miR-126-5p in lung adenocarcinoma and the possible mechanism]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1186-90. [PMID: 31801711 DOI: 10.12122/j.issn.1673-4254.2019.10.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Li Z, Li N, Wu M, Li X, Luo Z, Wang X. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Mol Cell Biochem 2013;381:233-42. [PMID: 23744532 DOI: 10.1007/s11010-013-1707-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
59 Feng Q, Wang D, Guo P, Zhang Z, Feng J. Long non-coding RNA HOTAIR promotes the progression of synovial sarcoma through microRNA-126/stromal cell-derived factor-1 regulation. Oncol Lett 2021;21:444. [PMID: 33868482 DOI: 10.3892/ol.2021.12705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Gao Y, Wang Y, Wang X, Zhao C, Wang F, Du J, Zhang H, Shi H, Feng Y, Li D, Yan J, Yao Y, Hu W, Ding R, Zhang M, Wang L, Huang C, Zhang J. miR-335-5p suppresses gastric cancer progression by targeting MAPK10. Cancer Cell Int 2021;21:71. [PMID: 33482821 DOI: 10.1186/s12935-020-01684-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Feng R, Sah BK, Beeharry MK, Yuan F, Su L, Jin X, Yan M, Liu B, Li C, Zhu Z. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients. Cancer Biomark 2018;21:335-43. [PMID: 29171987 DOI: 10.3233/CBM-170472] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
62 Khan GJ, Sun L, Abbas M, Naveed M, Jamshaid T, Baig MMFA, Yuan S. In-vitro Pre-Treatment of Cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies. CMP 2019;12:249-60. [DOI: 10.2174/1874467212666190306165703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
63 Yuan W, Guo YQ, Li XY, Deng MZ, Shen ZH, Bo CB, Dai YF, Huang MY, Yang ZY, Quan YS, Tian L, Wang X. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway. Oncotarget 2016;7:60230-44. [PMID: 27517626 DOI: 10.18632/oncotarget.11176] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
64 Wang ZX, Deng TX, Ma Z. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma. J Cell Biochem. 2019;120:16416-16426. [PMID: 31297864 DOI: 10.1002/jcb.28601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Yang J, Lan H, Huang X, Liu B, Tong Y. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. PLoS One. 2012;7:e42978. [PMID: 22900072 DOI: 10.1371/journal.pone.0042978] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
66 Beltrán-Anaya FO, Cedro-Tanda A, Hidalgo-Miranda A, Romero-Cordoba SL. Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism. Front Physiol 2016;7:342. [PMID: 27551267 DOI: 10.3389/fphys.2016.00342] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
67 Zhou W, Li X, Liu F, Xiao Z, He M, Shen S, Liu S. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys Sin (Shanghai) 2012;44:838-46. [PMID: 23017832 DOI: 10.1093/abbs/gms071] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
68 Grabon A, Bankaitis VA, McDermott MI. The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes. J Lipid Res 2019;60:242-68. [PMID: 30504233 DOI: 10.1194/jlr.R089730] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 8.8] [Reference Citation Analysis]
69 Noguchi S, Mori T, Hoshino Y, Yamada N, Maruo K, Akao Y. MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas: MicroRNA expression in canine and human melanomas. Vet Comp Oncol 2013;11:113-23. [DOI: 10.1111/j.1476-5829.2011.00306.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
70 Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, Kirita T, Kuniyasu H. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012;107:700-6. [PMID: 22836510 DOI: 10.1038/bjc.2012.330] [Cited by in Crossref: 126] [Cited by in F6Publishing: 124] [Article Influence: 12.6] [Reference Citation Analysis]
71 Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 2011;117:3193-200. [PMID: 21264844 DOI: 10.1002/cncr.25907] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
72 Xu Q, Luan T, Fu S, Yang J, Jiang C, Xia F. Effects of pitavastatin on the expression of VCAM-1 and its target gene miR-126 in cultured human umbilical vein endothelial cells. Cardiovasc Ther 2014;32:193-7. [PMID: 24870014 DOI: 10.1111/1755-5922.12081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
73 Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D. Prognostic value of microRNA-126 and CRK expression in gastric cancer. Onco Targets Ther 2016;9:6127-35. [PMID: 27785060 DOI: 10.2147/OTT.S87778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
74 Bibi F, Naseer MI, Alvi SA, Yasir M, Jiman-Fatani AA, Sawan A, Abuzenadah AM, Al-Qahtani MH, Azhar EI. microRNA analysis of gastric cancer patients from Saudi Arabian population. BMC Genomics. 2016;17:751. [PMID: 27766962 DOI: 10.1186/s12864-016-3090-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
75 Deng Y, Huang Z, Xu Y, Jin J, Zhuo W, Zhang C, Zhang X, Shen M, Yan X, Wang L. MiR-215 modulates gastric cancer cell proliferation by targeting RB1. Cancer Lett. 2014;342:27-35. [PMID: 23981575 DOI: 10.1016/j.canlet.2013.08.033] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
76 Li H, Liu G, Pan K, Miao X, Xie Y. Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1. Oncotarget 2017;8:95880-95. [PMID: 29221174 DOI: 10.18632/oncotarget.21431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
77 Nothnick WB. Non-coding RNAs in Uterine Development, Function and Disease. Adv Exp Med Biol 2016;886:171-89. [PMID: 26659492 DOI: 10.1007/978-94-017-7417-8_9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
78 Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, Tan P. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation: MicroRNA dysregulation in gastric cancer. Int J Cancer 2016;138:1337-49. [DOI: 10.1002/ijc.29627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
79 Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B, Zhu Z. MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer. 2014;14:34. [PMID: 24443799 DOI: 10.1186/1471-2407-14-34] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
80 Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38:724-733. [PMID: 22082758 DOI: 10.1053/j.seminoncol.2011.08.006] [Cited by in Crossref: 144] [Cited by in F6Publishing: 145] [Article Influence: 13.1] [Reference Citation Analysis]
81 Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, Su L, Li J, Chen X, Ju J. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett. 2012;586:2382-2388. [PMID: 22677169 DOI: 10.1016/j.febslet.2012.05.050] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
82 Salazar C, Calvopiña D, Punyadeera C. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Expert Rev Mol Diagn 2014;14:1033-40. [PMID: 25222489 DOI: 10.1586/14737159.2014.960519] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
83 Xiao J, Lin HY, Zhu YY, Zhu YP, Chen LW. MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Onco Targets Ther 2016;9:5181-93. [PMID: 27578985 DOI: 10.2147/OTT.S105198] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
84 Tang X, Li J, Yu B, Su L, Yu Y, Yan M, Liu B, Zhu Z. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer. Int J Biol Sci. 2013;9:55-66. [PMID: 23289017 DOI: 10.7150/ijbs.5280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
85 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
86 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
87 Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z. The interplay between m6A RNA methylation and noncoding RNA in cancer.J Hematol Oncol. 2019;12:121. [PMID: 31757221 DOI: 10.1186/s13045-019-0805-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 83] [Article Influence: 22.3] [Reference Citation Analysis]
88 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
89 Wang J, Zhou Y, Fei X, Chen X, Chen Y. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p. Sci Rep 2018;8:11094. [PMID: 30038373 DOI: 10.1038/s41598-018-29271-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
90 Mizuno K, Mataki H, Seki N, Kumamoto T, Kamikawaji K, Inoue H. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis. J Hum Genet 2017;62:57-65. [PMID: 27488441 DOI: 10.1038/jhg.2016.98] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
91 Tian Y, Xu Z, Fu J. CircularRNA-9119 promotes the proliferation of cervical cancer cells by sponging miR-126/MDM4. Mol Cell Biochem 2020;470:53-62. [PMID: 32385717 DOI: 10.1007/s11010-020-03745-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Feng R, Lu S, Sah BK, Beeharry MK, Zhang H, Yan M, Liu B, Li C, Zhu Z. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer. Cancer Biomark 2018;22:773-80. [PMID: 29843221 DOI: 10.3233/CBM-181324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Grabon A, Khan D, Bankaitis VA. Phosphatidylinositol transfer proteins and instructive regulation of lipid kinase biology. Biochim Biophys Acta 2015;1851:724-35. [PMID: 25592381 DOI: 10.1016/j.bbalip.2014.12.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
94 Bao J, Yu Y, Chen J, He Y, Chen X, Ren Z, Xue C, Liu L, Hu Q, Li J, Cui G, Sun R. MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death Dis 2018;9:1045. [PMID: 30315225 DOI: 10.1038/s41419-018-1020-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
95 Luo C, Weber CE, Osen W, Bosserhoff AK, Eichmüller SB. The role of microRNAs in melanoma. Eur J Cell Biol 2014;93:11-22. [PMID: 24602414 DOI: 10.1016/j.ejcb.2014.02.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
96 Tsuda M, Tanaka S. Roles for crk in cancer metastasis and invasion. Genes Cancer. 2012;3:334-340. [PMID: 23226571 DOI: 10.1177/1947601912458687] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
97 Wang J, Chen X, Su L, Li P, Cai Q, Liu B, Wu W, Zhu Z. MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1. Biomed Pharmacother 2015;72:66-73. [PMID: 26054677 DOI: 10.1016/j.biopha.2015.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
98 Zhu H, Sun B, Zhu L, Zou G, Shen Q. N6-Methyladenosine Induced miR-34a-5p Promotes TNF-α-Induced Nucleus Pulposus Cell Senescence by Targeting SIRT1. Front Cell Dev Biol 2021;9:642437. [PMID: 33763423 DOI: 10.3389/fcell.2021.642437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
99 Atanasov G, Dietel C, Feldbrügge L, Benzing C, Krenzien F, Brandl A, Katou S, Schierle K, Robson SC, Splith K, Wiltberger G, Reutzel-Selke A, Jonas S, Pascher A, Bahra M, Pratschke J, Schmelzle M. Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma. Oncotarget 2018;9:29921-33. [PMID: 30042823 DOI: 10.18632/oncotarget.25699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
100 Huang W, Lin J, Zhang H. miR-126: A novel regulator in colon cancer. Biomed Rep 2016;4:131-4. [PMID: 26893826 DOI: 10.3892/br.2015.549] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
101 Yücel EI, Sahin M. Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b. Mol Biol Rep 2020;47:1649-58. [DOI: 10.1007/s11033-020-05252-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun 2012;425:127-33. [PMID: 22809510 DOI: 10.1016/j.bbrc.2012.07.025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
103 Choudhury AR, Singh KK. Mitochondrial determinants of cancer health disparities. Semin Cancer Biol 2017;47:125-46. [PMID: 28487205 DOI: 10.1016/j.semcancer.2017.05.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
104 Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, Lu DS, Zou QM, Xiao B, Mao XH. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 2012;586:722-728. [PMID: 22321642 DOI: 10.1016/j.febslet.2012.01.025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
105 Tomasetti M, Santarelli L, Neuzil J, Dong L. MicroRNA regulation of cancer metabolism: role in tumour suppression. Mitochondrion 2014;19:29-38. [DOI: 10.1016/j.mito.2014.06.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
106 Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30:255-267. [PMID: 22722550 DOI: 10.1159/000336919] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
107 Feng R, Sah BK, Li J, Lu S, Yuan F, Jin X, Yan M, Liu B, Li C, Zhu Z. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Cancer Biomark 2018;23:437-45. [PMID: 30248047 DOI: 10.3233/CBM-181526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Hatziapostolou M, Polytarchou C, Iliopoulos D. miRNAs link metabolic reprogramming to oncogenesis. Trends Endocrinol Metab 2013;24:361-73. [PMID: 23602813 DOI: 10.1016/j.tem.2013.03.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
109 Wang Q, Yu J. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol. 2018;96:19-25. [PMID: 28482162 DOI: 10.1139/bcb-2016-0254] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
110 Lei YP, Chen HX, Zhou XD. MiR-126 regulates the expression of vascular endothelial growth factor A and its downstream target proteins Akt, mTOR and Erk1/2 in gastric cancer cells. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4116-4120 [DOI: 10.11569/wcjd.v21.i36.4116] [Reference Citation Analysis]
111 Wang J, Zhou Y, Fei X, Chen X, Chen R, Zhu Z, Chen Y. Integrative bioinformatics analysis identifies ROBO1 as a potential therapeutic target modified by miR-218 in hepatocellular carcinoma. Oncotarget 2017;8:61327-37. [PMID: 28977866 DOI: 10.18632/oncotarget.18099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
112 Ye S, Yu C, Zhang G, Shi F, Chen Y, Yang J, Wu W, Zhou Y. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease. Oncol Lett 2020;20:2411-9. [PMID: 32782558 DOI: 10.3892/ol.2020.11796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Bu J, Li H, Li XY, Liu LH, Sun W, Xiao T. Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis. Dis Markers 2015;2015:739469. [PMID: 26351404 DOI: 10.1155/2015/739469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
114 Liu S, Gao S, Wang XY, Wang DB. Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Arch Gynecol Obstet 2012;285:1065-72. [PMID: 22012249 DOI: 10.1007/s00404-011-2112-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
115 Santarelli L, Staffolani S, Strafella E, Nocchi L, Manzella N, Grossi P, Bracci M, Pignotti E, Alleva R, Borghi B, Pompili C, Sabbatini A, Rubini C, Zuccatosta L, Bichisecchi E, Valentino M, Horwood K, Comar M, Bovenzi M, Dong L, Neuzil J, Amati M, Tomasetti M. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. Lung Cancer 2015;90:457-64. [DOI: 10.1016/j.lungcan.2015.09.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
116 Watt K, Tyryshkin K, Renwick N, Craig AWB. Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma. Transl Oncol 2020;13:100802. [PMID: 32474365 DOI: 10.1016/j.tranon.2020.100802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S, Zou X. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 2011;6:e20341. [PMID: 21647377 DOI: 10.1371/journal.pone.0020341] [Cited by in Crossref: 153] [Cited by in F6Publishing: 151] [Article Influence: 13.9] [Reference Citation Analysis]
118 Lechman ER, Gentner B, van Galen P, Giustacchini A, Saini M, Boccalatte FE, Hiramatsu H, Restuccia U, Bachi A, Voisin V, Bader GD, Dick JE, Naldini L. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell 2012;11:799-811. [PMID: 23142521 DOI: 10.1016/j.stem.2012.09.001] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 14.3] [Reference Citation Analysis]
119 Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, Zuo D, Madore J, Monast A, Mes-Masson AM, Grosset AA, Gaboury L, Hallet M, Siegel P, Park M. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Res 2012;14:R74. [PMID: 22569336 DOI: 10.1186/bcr3183] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
120 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
121 Ouyang Y, Yuan W, Qiu S. MicroRNA-153 functions as a tumor suppressor in gastric cancer via targeting Kruppel-like factor 5. Exp Ther Med 2018;16:473-82. [PMID: 30112020 DOI: 10.3892/etm.2018.6226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
122 Li N, Tang A, Huang S, Li Z, Li X, Shen S, Ma J, Wang X. MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway. Mol Cell Biochem 2013;380:107-19. [PMID: 23615712 DOI: 10.1007/s11010-013-1664-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
123 Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, Keller A, Habib NA, Stebbing J, Castellano L. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One. 2012;7:e32068. [PMID: 22384141 DOI: 10.1371/journal.pone.0032068] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 9.2] [Reference Citation Analysis]
124 Wu J, Yang L, Shan Y, Cai C, Wang S, Zhang H. AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway. Oncol Lett 2016;11:1889-94. [PMID: 26998095 DOI: 10.3892/ol.2016.4110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
125 Huang Q, Ouyang X. The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data. Future Oncol 2015;11:141-51. [PMID: 25572789 DOI: 10.2217/fon.14.161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Yang Q, Zhang RW, Sui PC, He HT, Ding L. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol 2015; 21(39): 10956-10981 [PMID: 26494954 DOI: 10.3748/wjg.v21.i39.10956] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
127 Wei L, Chen Z, Cheng N, Li X, Chen J, Wu D, Dong M, Wu X. MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy. Onco Targets Ther 2020;13:2459-68. [PMID: 32273718 DOI: 10.2147/OTT.S238348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
128 Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG. Effects of Herb-Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2017;2017:1767301. [PMID: 28246536 DOI: 10.1155/2017/1767301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
129 Feng X, Wang H, Ye S, Guan J, Tan W, Cheng S, Wei G, Wu W, Wu F, Zhou Y. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One. 2012;7:e52782. [PMID: 23285182 DOI: 10.1371/journal.pone.0052782] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 7.9] [Reference Citation Analysis]
130 Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N. Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line. Iran J Cancer Prev 2016;9:e4190. [PMID: 27761206 DOI: 10.17795/ijcp-4190] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
131 Lin J, Liu Z, Liao S, Li E, Wu X, Zeng W. Elevated microRNA-7 inhibits proliferation and tumor angiogenesis and promotes apoptosis of gastric cancer cells via repression of Raf-1. Cell Cycle 2020;19:2496-508. [PMID: 32931357 DOI: 10.1080/15384101.2020.1807670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Uysal-Onganer P, D'Alessio S, Mortoglou M, Kraev I, Lange S. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. Int J Mol Sci 2021;22:1396. [PMID: 33573274 DOI: 10.3390/ijms22031396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston M. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford). 2013;15:260-264. [PMID: 23458262 DOI: 10.1111/j.1477-2574.2012.00523.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
134 Wang H, Wang J, Sun S, Wang Y, Guo J, Ning C, Yang K, Liu JF. Identification of reference microRNAs for quantitative expression analysis in porcine peripheral blood mononuclear cells treated with polyinosinic-polycytidylic acid. Int J Immunogenet 2015;42:217-25. [PMID: 25817599 DOI: 10.1111/iji.12198] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
135 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
136 Wang P, Li Z, Liu H, Zhou D, Fu A, Zhang E. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2. Biochem Biophys Res Commun. 2016;479:91-96. [PMID: 27622325 DOI: 10.1016/j.bbrc.2016.09.040] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
137 Bell ES, Park M. Models of crk adaptor proteins in cancer. Genes Cancer 2012;3:341-52. [PMID: 23226572 DOI: 10.1177/1947601912459951] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
138 Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. Tumour Biol 2012;33:157-72. [PMID: 22072212 DOI: 10.1007/s13277-011-0259-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
139 Chen L, Lü MH, Zhang D, Hao NB, Fan YH, Wu YY, Wang SM, Xie R, Fang DC, Zhang H. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis. 2014;5:e1034. [PMID: 24481448 DOI: 10.1038/cddis.2013.553] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 10.9] [Reference Citation Analysis]
140 Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845:255-265. [PMID: 24569228 DOI: 10.1016/j.bbcan.2014.02.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 96] [Article Influence: 4.8] [Reference Citation Analysis]
141 Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnæs E, Rossing M, Specht L, Therkildsen MH, Nauntofte B, Dabelsteen S, von Buchwald C. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 2011;104:830-40. [PMID: 21326242 DOI: 10.1038/bjc.2011.29] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 12.1] [Reference Citation Analysis]
142 Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 2014;5:11873-85. [PMID: 25428912 DOI: 10.18632/oncotarget.2662] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 12.1] [Reference Citation Analysis]
143 Hamada S, Satoh K, Miura S, Hirota M, Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol. 2013;228:1255-1263. [PMID: 23139153 DOI: 10.1002/jcp.24280] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
144 Chen H, Miao R, Fan J, Han Z, Wu J, Qiu G, Tang H, Peng Z. Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma. Clin Exp Metastasis 2013;30:651-8. [PMID: 23378255 DOI: 10.1007/s10585-013-9569-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
145 Zhang Y, Zang M, Li J, Ji J, Zhang J, Liu X, Qu Y, Su L, Li C, Yu Y. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer. Acta Biochim Biophys Sin (Shanghai). 2014;46:283-290. [PMID: 24492534 DOI: 10.1093/abbs/gmu001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
146 Tafsiri E, Darbouy M, Shadmehr MB, Zagryazhskaya A, Alizadeh J, Karimipoor M. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features. Tumour Biol. 2015;36:1603-1612. [PMID: 25384507 DOI: 10.1007/s13277-014-2755-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
147 Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2011;1:21. [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
148 Wirbisky SE, Weber GJ, Schlotman KE, Sepúlveda MS, Freeman JL. Embryonic atrazine exposure alters zebrafish and human miRNAs associated with angiogenesis, cancer, and neurodevelopment. Food Chem Toxicol 2016;98:25-33. [PMID: 27046698 DOI: 10.1016/j.fct.2016.03.027] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
149 Png KJ, Halberg N, Yoshida M, Tavazoie SF. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2012;481:190-194. [PMID: 22170610 DOI: 10.1038/nature10661] [Cited by in Crossref: 354] [Cited by in F6Publishing: 340] [Article Influence: 32.2] [Reference Citation Analysis]
150 Wei Y, Wang Y, Zang A, Wang Z, Fang G, Hong D. MiR-4766-5p Inhibits The Development And Progression Of Gastric Cancer By Targeting NKAP. Onco Targets Ther 2019;12:8525-36. [PMID: 31802890 DOI: 10.2147/OTT.S220234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
151 Zhao Y, Li C, Wang M, Su L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B. Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer. PLoS One. 2013;8:e69756. [PMID: 23936094 DOI: 10.1371/journal.pone.0069756] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
152 Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun. 2013;4:1877. [PMID: 23695671 DOI: 10.1038/ncomms2876] [Cited by in Crossref: 199] [Cited by in F6Publishing: 195] [Article Influence: 22.1] [Reference Citation Analysis]
153 Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, Wu J, Zheng S. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J Transl Med 2014;12:259. [PMID: 25240815 DOI: 10.1186/s12967-014-0259-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 9.1] [Reference Citation Analysis]
154 Yang Y, Song KL, Chang H, Chen L. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer. Diagn Pathol 2014;9:220. [PMID: 25551621 DOI: 10.1186/s13000-014-0220-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
155 Guo C, Pan Q, Xiong H, Qiao Y, Bian Z, Zhong W, Sheng L, Li H, Shen L, Hua J, Ma X, Fang J. Dynamic expression of miR-126 and its effects on proliferation and contraction of hepatic stellate cells. FEBS Letters 2013;587:3792-801. [DOI: 10.1016/j.febslet.2013.09.047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
156 Gasperi V, Vangapandu C, Savini I, Ventimiglia G, Adorno G, Catani MV. Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines. J Nutr Biochem 2019;74:108242. [PMID: 31665654 DOI: 10.1016/j.jnutbio.2019.108242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
157 Iliou MS, da Silva-Diz V, Carmona FJ, Ramalho-Carvalho J, Heyn H, Villanueva A, Muñoz P, Esteller M. Impaired DICER1 function promotes stemness and metastasis in colon cancer. Oncogene 2014;33:4003-15. [PMID: 24096488 DOI: 10.1038/onc.2013.398] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
158 Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo M, Dong L, Yin H, Gong B, Li Z. MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. PLoS One. 2014;9:e88057. [PMID: 24498243 DOI: 10.1371/journal.pone.0088057] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
159 Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015;22:291-301. [DOI: 10.1038/cgt.2015.19] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
160 Liu Y, Zhou Y, Feng X, Yang P, Yang J, An P, Wang H, Ye S, Yu C, He Y, Luo H. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer 2014;53:358-65. [PMID: 24532280 DOI: 10.1002/gcc.22146] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
161 Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev 2019;38:537-48. [PMID: 31486976 DOI: 10.1007/s10555-019-09803-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
162 Tayel SI, Saleh AA, El-Hefnawy SM, Elzorkany KM, Elgarawany GE, Noreldin RI. Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin. Curr Mol Med 2020;20:361-71. [PMID: 31629394 DOI: 10.2174/1566524019666191019103918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Lu W, Tao X, Fan Y, Tang Y, Xu X, Fan S, Huang Y, Yu Y, Luo D. LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis. Onco Targets Ther 2018;11:4431-42. [PMID: 30104884 DOI: 10.2147/OTT.S164711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
164 Xiao J, Lai H, Wei SH, Ye ZS, Gong FS, Chen LC. lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.Cancer Med. 2019;8:6768-6779. [PMID: 31517442 DOI: 10.1002/cam4.1302] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
165 Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011;89:445-57. [PMID: 21234533 DOI: 10.1007/s00109-010-0716-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 80] [Article Influence: 9.1] [Reference Citation Analysis]
166 Wang J, Zhou Y, Fei X, Chen X, Zhu Z. Regulator of G-protein signaling 3 targeted by miR-126 correlates with poor prognosis in gastric cancer patients. Anticancer Drugs 2017;28:161-9. [PMID: 27754994 DOI: 10.1097/CAD.0000000000000446] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
167 Grange C, Collino F, Tapparo M, Camussi G. Oncogenic micro-RNAs and Renal Cell Carcinoma. Front Oncol 2014;4:49. [PMID: 24672771 DOI: 10.3389/fonc.2014.00049] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
168 Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett. 2012;320:189-197. [PMID: 22388101 DOI: 10.1016/j.canlet.2012.02.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
169 Luo J, Zhu C, Wang H, Yu L, Zhou J. MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor. Oncol Lett 2018;15:5803-8. [PMID: 29552211 DOI: 10.3892/ol.2018.8025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
170 Liu H, Ren SY, Qu Y, Liu C, Zhang Y, Li XQ, Ma H. MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk. Kaohsiung J Med Sci 2020;36:265-73. [PMID: 31889432 DOI: 10.1002/kjm2.12180] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
171 Xu Y, Deng Y, Yan X, Zhou T. Targeting miR-375 in gastric cancer. Expert Opin Ther Targets 2011;15:961-72. [PMID: 21557705 DOI: 10.1517/14728222.2011.581232] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
172 Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol. 2013;15:546-554. [PMID: 23728460 DOI: 10.1038/ncb2769] [Cited by in Crossref: 210] [Cited by in F6Publishing: 215] [Article Influence: 23.3] [Reference Citation Analysis]
173 He Y, Bai J, Liu P, Dong J, Tang Y, Zhou J, Han P, Xing J, Chen Y, Yu X. miR-494 protects pancreatic β-cell function by targeting PTEN in gestational diabetes mellitus. EXCLI J 2017;16:1297-307. [PMID: 29333131 DOI: 10.17179/excli2017-491] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
174 Hosseinahli N, Aghapour M, Duijf PHG, Baradaran B. Treating cancer with microRNA replacement therapy: A literature review. J Cell Physiol. 2018;233:5574-5588. [PMID: 29521426 DOI: 10.1002/jcp.26514] [Cited by in Crossref: 151] [Cited by in F6Publishing: 148] [Article Influence: 37.8] [Reference Citation Analysis]
175 Drury R, Verghese ET, Hughes TA. The roles of microRNAs in sarcomas. J Pathol 2012;227:385-91. [DOI: 10.1002/path.4037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
176 Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J, Feng F. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget 2015;6:17559-69. [PMID: 25654811 DOI: 10.18632/oncotarget.2755] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 11.8] [Reference Citation Analysis]
177 Liu Y, Zhou Y, Gong X, Zhang C. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor. Exp Ther Med 2017;14:173-80. [PMID: 28672911 DOI: 10.3892/etm.2017.4477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
178 Rao ZZ, Zhang XW, Ding YL, Yang MY. miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3. PLoS One 2017;12:e0178702. [PMID: 28575098 DOI: 10.1371/journal.pone.0178702] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
179 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 99] [Cited by in F6Publishing: 55] [Article Influence: 14.1] [Reference Citation Analysis]
180 Su Y, Li X, Ji W, Sun B, Xu C, Li Z, Qian G, Su C. Small molecule with big role: MicroRNAs in cancer metastatic microenvironments. Cancer Lett 2014;344:147-56. [PMID: 24184826 DOI: 10.1016/j.canlet.2013.10.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
181 Calcagno DQ, de Arruda Cardoso Smith M, Burbano RR. Cancer type-specific epigenetic changes: gastric cancer. Methods Mol Biol. 2015;1238:79-101. [PMID: 25421656 DOI: 10.1007/978-1-4939-1804-1_5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
182 Tsai MM, Wang CS, Tsai CY, Huang HW, Chi HC, Lin YH, Lu PH, Lin KH. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016;17:pii: E945. [PMID: 27322246 DOI: 10.3390/ijms17060945] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
183 Wang Z, Liu X, Liu X, Niu D. Long Non-Coding RNA BLACAT1 Promotes the Tumorigenesis of Gastric Cancer by Sponging microRNA-149-5p and Targeting KIF2A. Cancer Manag Res 2020;12:6629-40. [PMID: 32801897 DOI: 10.2147/CMAR.S258178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Hua Y, Liang C, Miao C, Wang S, Su S, Shao P, Liu B, Bao M, Zhu J, Xu A, Zhang J, Li J, Wang Z. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncol Lett 2018;15:9051-60. [PMID: 29805636 DOI: 10.3892/ol.2018.8528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
185 Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases. Ann Surg Oncol 2014;21:1046-54. [PMID: 24242678 DOI: 10.1245/s10434-013-3361-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
186 Liu X, Ma R, Yi B, Riker AI, Xi Y. MicroRNAs are involved in the development and progression of gastric cancer. Acta Pharmacol Sin 2021;42:1018-26. [PMID: 33037405 DOI: 10.1038/s41401-020-00540-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
187 Fujiwara W, Kato Y, Hayashi M, Sugishita Y, Okumura S, Yoshinaga M, Ishiguro T, Yamada R, Ueda S, Harada M, Naruse H, Ishii J, Ozaki Y, Izawa H. Serum microRNA-126 and -223 as new-generation biomarkers for sarcoidosis in patients with heart failure. J Cardiol 2018;72:452-7. [PMID: 30054123 DOI: 10.1016/j.jjcc.2018.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
188 Aslan E, Akbas E, Yilmaz S, Karaoglu AS, Telli U, Yildirim S, Gudek H, Kalcioglu MT, Yilmaz S, Akalin I. Ear atresia: Is there a role of apoptosis-regulating miRNAs? North Clin Istanb 2018;5:238-45. [PMID: 30688935 DOI: 10.14744/nci.2017.26680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Huang TH, Chu TY. Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer. Oncogene 2014;33:3636-47. [PMID: 24037526 DOI: 10.1038/onc.2013.335] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
190 Sepahi N, Kohan L, Jahromi AR, Daneshbod Y, Hoveidi EN. mir-126 rs4636297 and TGFβRI rs334348 functional gene variants are associated with susceptibility to endometriosis and its severity. Gynecological Endocrinology 2017;33:429-32. [DOI: 10.1080/09513590.2017.1290064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
191 Timoneda O, Balcells I, Córdoba S, Castelló A, Sánchez A. Determination of reference microRNAs for relative quantification in porcine tissues. PLoS One. 2012;7:e44413. [PMID: 22970213 DOI: 10.1371/journal.pone.0044413] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
192 Witwer KW, Halushka MK. Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research. RNA Biol 2016;13:1103-16. [PMID: 27645402 DOI: 10.1080/15476286.2016.1236172] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 13.7] [Reference Citation Analysis]